CA
NZ
UK
AU
IND
US
…
Silex Systems Limited, a technology commercialization company, engages in the research and development, commercialization, and license of SILEX laser enrichment technology in Australia, the United States, and the United Kingdom. It operates through three segments: Silex Systems, Translucent, and Silex USA. The company also sells its cREO technology. In addition, it develops its laser-based enrichment technology for use in various applications comprising uranium production and enrichment for nuclear power; silicon enrichment for silicon quantum computing; and medical isotope enrichment for new cancer therapies. Silex Systems Limited was incorporated in 1987 and is based in Lucas Heights, Australia.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Silex Systems is an Australian company that develops and licenses laser-based isotope separation technology, mainly for uranium enrichment. Growth drivers include commercial adoption of the SILEX process, licensing revenue from partners, and sustained demand for low-carbon nuclear fuel, which may attract investors seeking exposure to specialized enabling technology.
Key risks are commercialization and execution uncertainty, regulatory and licensing hurdles in the nuclear supply chain, dependence on a small number of partners and capital-intensive project funding, and sensitivity to uranium prices and policy shifts.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Income before tax | -41.75M | -42.56M | -22.73M | -17.36M | -9.46M |
| Net income | -38.62M | -42.56M | -22.73M | -17.36M | -9.46M |
| Selling general administrative | - | 10.79M | 1.12M | 7.69M | 5.97M |
| Selling and marketing expenses | - | - | 0.16M | - | - |
| Gross profit | -0.50M | 6.79M | -5.09M | -4.27M | -2.86M |
| Reconciled depreciation | - | 0.50M | 0.43M | 0.38M | 0.44M |
| Ebit | -4.49M | -42.47M | -22.69M | -17.28M | -9.46M |
| Ebitda | -3.99M | -41.97M | -22.27M | -16.89M | -9.02M |
| Depreciation and amortization | 0.51M | 0.50M | 0.43M | 0.38M | 0.44M |
| Operating income | -4.49M | -12.84M | -10.11M | -3.08M | -2.28M |
| Other operating expenses | 18.20M | 19.64M | 16.22M | 29.37M | 16.06M |
| Interest expense | 0.07M | 0.09M | 0.04M | 0.05M | 0.02M |
| Tax provision | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Interest income | - | 4.94M | 6.04M | 16.65M | 0.18M |
| Net interest income | - | 4.85M | 6.00M | 2.35M | 0.16M |
| Income tax expense | -3.13M | - | -23.22M | -13.00M | -5.11M |
| Total revenue | 13.71M | 6.79M | 6.11M | 6.12M | 4.22M |
| Total operating expenses | 3.99M | 19.64M | 5.02M | 12.75M | 8.72M |
| Cost of revenue | 14.21M | 12.47M | 11.20M | 10.40M | 7.08M |
| Total other income expense net | -37.26M | -29.71M | -12.62M | -13.08M | -5.12M |
| Net income from continuing ops | - | -42.56M | -22.73M | -17.36M | -9.46M |
| Net income applicable to common shares | - | -42.56M | -22.73M | -17.36M | -9.46M |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Total assets | 208.07M | 98.96M | 141.56M | 152.20M | 54.12M |
| Other current assets | 0.87M | 1.07M | 1.13M | 0.83M | 0.33M |
| Total liab | 6.88M | 8.01M | 9.62M | 3.51M | 3.57M |
| Total stockholder equity | 201.20M | 90.95M | 131.94M | 148.69M | 50.55M |
| Other current liab | 1.43M | 5.62M | 1.56M | 2.38M | 1.12M |
| Common stock | 539.79M | 392.70M | 390.67M | 386.75M | 271.54M |
| Capital stock | - | 392.70M | 390.67M | 386.75M | 271.54M |
| Retained earnings | -355.60M | -314.69M | -272.14M | -249.40M | -232.04M |
| Other liab | - | - | - | 0.09M | 0.07M |
| Cash | 16.03M | 19.75M | 18.89M | 2.86M | 5.04M |
| Total current liabilities | 6.46M | 7.27M | 8.62M | 2.88M | 2.72M |
| Current deferred revenue | 3.49M | - | 4.45M | -0.23M | 0.92M |
| Net debt | -15.39M | -18.84M | -17.71M | -2.09M | -4.05M |
| Short term debt | 0.31M | 0.56M | 0.27M | 0.23M | 0.20M |
| Short long term debt total | 0.64M | 0.91M | 1.18M | 0.77M | 0.98M |
| Other stockholder equity | - | - | - | -137.35M | -39.50M |
| Property plant equipment | - | - | - | 1.04M | 1.31M |
| Total current assets | 190.20M | 89.67M | 126.73M | 147.53M | 49.68M |
| Long term investments | - | 8.05M | 13.27M | 3.63M | 3.12M |
| Net tangible assets | - | - | - | 148.69M | 50.55M |
| Short term investments | 164.71M | 62.21M | 98.11M | 137.88M | 41.50M |
| Net receivables | 8.59M | 6.64M | 8.61M | 5.96M | 2.82M |
| Accounts payable | 1.22M | 1.09M | 2.35M | 0.50M | 0.48M |
| Accumulated other comprehensive income | 17.00M | 12.94M | 13.41M | 11.34M | 11.04M |
| Non currrent assets other | - | - | - | -4.67M | -4.43M |
| Non current assets total | 17.87M | 9.29M | 14.83M | 4.67M | 4.43M |
| Capital lease obligations | - | 0.91M | 1.18M | 0.77M | 0.98M |
| Long term debt total | - | - | - | 0.54M | 0.78M |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Investments | - | -2.61M | 7.56M | -114.40M | -39.94M |
| Change to liabilities | - | - | - | 0.10M | 0.59M |
| Total cashflows from investing activities | -155.67M | -2.61M | 7.56M | -114.40M | -40.06M |
| Net borrowings | - | - | - | -0.23M | -0.30M |
| Total cash from financing activities | 143.93M | 0.40M | 2.34M | 114.55M | 38.20M |
| Change to operating activities | - | - | - | -3.17M | -0.14M |
| Net income | -38.62M | -42.56M | -22.73M | -17.36M | -9.46M |
| Change in cash | -27.42M | 0.86M | 16.03M | -2.18M | -1.37M |
| Begin period cash flow | 43.46M | 18.89M | 2.86M | 5.04M | 6.40M |
| End period cash flow | 16.03M | 19.75M | 18.89M | 2.86M | 5.04M |
| Total cash from operating activities | 8.18M | 3.02M | 6.14M | -2.34M | 0.41M |
| Issuance of capital stock | - | 0.70M | 2.59M | 114.78M | 38.50M |
| Depreciation | 0.51M | - | 0.43M | 0.38M | 0.44M |
| Other cashflows from investing activities | 3.43M | 0.00M | 0.02M | -114.30M | -39.94M |
| Change to account receivables | -1.95M | 1.97M | -2.64M | -0.42M | -0.11M |
| Sale purchase of stock | - | 0.70M | 2.59M | 114.78M | 38.50M |
| Other cashflows from financing activities | -0.30M | -0.29M | -0.25M | -0.23M | -0.30M |
| Change to netincome | - | - | - | 18.13M | 9.08M |
| Capital expenditures | 0.11M | 0.16M | 0.29M | 0.09M | 0.13M |
| Change in working capital | -2.61M | 0.69M | 2.76M | -0.42M | -0.11M |
| Stock based compensation | - | - | - | 1.86M | 1.08M |
| Other non cash items | 48.91M | 2.33M | 28.87M | 14.64M | 9.44M |
| Free cash flow | 8.08M | 2.86M | 5.85M | -2.43M | 0.29M |
Sector: Technology Industry: Semiconductors
|
Stock Name
|
Change
(AUD) |
Price
(AUD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| SLX SILEX Systems Ltd |
-0.23 7.19% |
2.97 | - | 769.23 | 47.29 | 4.18 | 49.82 | -62.48 |
| WBT Weebit Nano Ltd |
-0.20 8.55% |
2.14 | - | - | 37.25 | 3.41 | 23.39 | -28.24 |
| BRN Brainchip Holdings Ltd |
-0.01 4.76% |
0.10 | - | - | 120.58 | 8.94 | 75.29 | 589.01 |
| AXE Archer Materials Ltd |
0.03 15.62% |
0.18 | - | 15.95 | 19.35 | 4.23 | 4502.73 | -4.80 |
| 4DS 4DS Memory Ltd |
- -% |
0.01 | - | - | 34.19 | 2.39 | 1000000.00 | -7.27 |
Silex Systems Limited, a technology commercialization company, engages in the research and development, commercialization, and license of SILEX laser enrichment technology in Australia, the United States, and the United Kingdom. It operates through three segments: Silex Systems, Translucent, and Silex USA. The company also sells its cREO technology. In addition, it develops its laser-based enrichment technology for use in various applications comprising uranium production and enrichment for nuclear power; silicon enrichment for silicon quantum computing; and medical isotope enrichment for new cancer therapies. Silex Systems Limited was incorporated in 1987 and is based in Lucas Heights, Australia.
| Name | Title | Year Born |
|---|---|---|
| Dr. Michael P. Goldsworthy B.Sc., BSc (Hons), FAIP, GAICD, M.Sc., MSc, Ph.D. | CEO, MD & Exec. Director | 1958 |
| Ms. Julie E. Ducie B.Bus., C.A., CA, GAICD, M.B.A. | CFO & Company Sec. | NA |
| Dr. Geordie Graetz | Chief Commercial Officer | NA |
| Dr. Michael P. Goldsworthy B.Sc., BSc (Hons), FAIP, GAICD, M.Sc., MSc, Ph.D. | CEO, MD & Executive Director | 1958 |
| Ms. Julie E Russell B.Bus., C.A., CA, GAICD, M.B.A. | CFO & Company Secretary | NA |
| Dr. Geordie Graetz M.A., Ph.D. | Chief Commercial Officer | NA |
| Dr. Michael P. Goldsworthy B.Sc., BSc (Hons), FAIP, GAICD, M.Sc., MSc, Ph.D. | CEO, MD & Executive Director | 1958 |
| Ms. Julie E Russell B.Bus., C.A., CA, GAICD, M.B.A. | CFO & Company Secretary | NA |
| Dr. Geordie Graetz M.A., Ph.D. | Chief Commercial Officer | NA |
| Dr. Michael P. Goldsworthy B.Sc., BSc (Hons), FAIP, GAICD, M.Sc., MSc, Ph.D. | CEO, MD & Executive Director | 1958 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
+0.61%
Communication Services
-0.21%
Consumer Cyclical
-0.26%
Consumer Defensive
-0.37%
Energy
+0.23%
Financial Services
-0.43%
Financials
+0.39%
Healthcare
+0.88%
Industrials
+0.36%
Real Estate
-0.51%
Technology
+1.35%
Utilities
+0.19%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...